According to the official website of the State Food and drug administration, the State Food and Drug Administration recently issued an announcement to cancel 223 drug registration certificates such as rosiglitazone maleate tablets. The reporter found that the drugs that cancelled the drug registration certificate this time include rosiglitazone maleate tablets, hydroxypropyl methylcellulose eye drops, Cimetidine Tablets, methyltestosterone tablets, compound acetylsalicylic acid tablets, chloramphenicol tablets, azithromycin tablets, children's compound sulfamethoxazole tablets, etc., involving many enterprises. Among them, GlaxoSmithKline (Tianjin) Co., Ltd. cancelled 4, Pfizer Pharmaceutical Co., Ltd. cancelled 5, Suzhou Yifan Pharmaceutical Co., Ltd. cancelled 20, Hainan Boda pharmaceutical factory cancelled 18, and Ningxia Qiyuan National Pharmaceutical Co., Ltd. cancelled 101. From the common name, among the drugs announced to be cancelled, the cancellation numbers of glucose injection, oxygen, analgin tablets, oxytetracycline tablets, tetracycline tablets, furazolidone tablets and vitamin C injection are all 5 or more. From the cancellation situation, except for the oxygen held by Ningxia Xingping Fine Chemical Co., Ltd. and the anti wind dampness liquid, rheumatism analgesic medicinal liquor and Xueqi medicinal liquor held by Ningxia Rongsheng Pharmaceutical Co., Ltd., the other 219 drugs are cancelled according to the application. According to the data, Article 83 of the drug administration law of the people's Republic of China stipulates that after evaluation, the drug registration certificate shall be cancelled for drugs with uncertain curative effect, serious adverse reactions or endangering human health for other reasons. Drugs whose drug registration certificates have been cancelled may not be produced, imported, sold or used. If the registration period of drugs has expired, the drug supervision and administration department shall take other measures such as canceling the certificate of harmless drugs or canceling the certificate of harmless drugs according to law. (outlook new era)